Page 43 of 248
Interview with Jean Gariepy, PhD
Jean Gariepy, Ph.D. Professor Departments of Medical Biophysics and Pharmaceutical Sciences University of Toronto SRI Research Chair in Biomolecular Engineering and Senior Scientist Physical Sciences Sunnybrook Research Institute
July 14, 2016
Interview with Eli Gilboa, PhD
Eli Gilboa Ph.D. Dodson Professor of Microbiology & Immunology University of Miami Miller School of Medicine How did you become interested in the field of oligonucleotides? A main interest and focus of my lab is cancer immunotherapy. The overall approach has been
October 22, 2015
Interview with Maureen McKeague, PhD
Maureen McKeague, PhD, Postdoctoral Scholar, Bioengineering Department, Stanford University How did you become interested in the field? I’ve been fascinated with nucleic acids ever since high school biology. In my undergraduate degree, I enjoyed genetics
June 23, 2015
Interview with Gerald Zon, PhD, FRSC
How did you become interested in the field? I was working in 1981 as an organic chemist at NIH in the former FDA Bureau of Biologics (now Center for Drug Evaluation & Research), and was asked to help clone the gene for human C-reactive protein by making the required hybridization probe—a mixed-sequence 11-mer oligodeoxynucleotide,
February 11, 2015
Interview with Takenori Shimo, Doctoral Candidate at Osaka University
Takenori Shimo received both his B.S. and M.Sc. in Pharmaceutical Sciences from Osaka University, Japan. He is currently a doctoral candidate in the Graduate School of Pharmaceutical Sciences, Osaka University. His research interests include nucleic acid chemistry, especially modulating splicing by using antisense oligonucleotides.
August 21, 2014
Page 43 of 248
